Lymphodepletion chemotherapy revitalizes chimeric antigen receptor T cells contributing to regression of relapsed B-cell lymphoma: A case report

INTRODUCTION: Chimeric antigen receptor T cells (CAR-T) targeting CD19 have shown great potential for treatment of B-cell malignancies. For those patients who can not achieve complete remission (CR) or suffer from relapse after CAR-T therapy, further therapeutic strategies still remain elusive. Whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Zuyu, Zhang, Hao, Shao, Mi, Cui, Qu, Wu, Zhao, Xiao, Lei, Huang, He, Hu, Yongxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581168/
https://www.ncbi.nlm.nih.gov/pubmed/33120740
http://dx.doi.org/10.1097/MD.0000000000022510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581168/
https://www.ncbi.nlm.nih.gov/pubmed/33120740
http://dx.doi.org/10.1097/MD.0000000000022510

Ejemplares similares